How Predictive Oncology is changing the landscape of oncology drug discovery and enabling the development of more effective therapies in the treatment of cancer. Listen to highlights from our presentation at the recent Investor Summit we attended in New York. First up in this clip is Dr. Pamela Bush, SVP of Strategic Sales and Business Development, followed by Bob Myers, CFO, and a warp-up with Raymond Vennare, CEO and Chairman of the Board.

Predictive Oncology
Molecule to Market podcast: Dr. Pamela Bush
“Pamela’s unwavering passion for a cancer cure paved the way for an incredible opportunity to directly make a difference in the lives of countless people,”